GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
6CW6 | K7N5M3 | Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR | |
6CW6 | 6CW6 | Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR | |
6CW6 | K7N5M3 | Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR | |
6CW6 | 6CW6 | Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR | |
6CW6 | K7N5M4 | Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR | |
6CW6 | K7N5M4 | Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR | |
6CVM | P00722 | Atomic resolution cryo-EM structure of beta-galactosidase | |
6CVB | A0A0X7Z9B1 | CryoEM structure of human enterovirus D68 in complex with 6'-sialyl-N-acetyllactosamine | |
6CVB | E9RIT6 | CryoEM structure of human enterovirus D68 in complex with 6'-sialyl-N-acetyllactosamine | |
6CVB | A0A097ZN88 | CryoEM structure of human enterovirus D68 in complex with 6'-sialyl-N-acetyllactosamine | |
6CVB | A0A0P0DH17 | CryoEM structure of human enterovirus D68 in complex with 6'-sialyl-N-acetyllactosamine | |
6CV7 | Q99PJ1 | Mouse Protocadherin-15 Extracellular Cadherin Domains 1 through 3 | |
6CV0 | F4MIW6 | Cryo-electron microscopy structure of infectious bronchitis coronavirus spike protein | Spike protein |
6CUG | P29016 | Crystal structure of BC8B TCR-CD1b-PC complex | |
6CUG | P61769 | Crystal structure of BC8B TCR-CD1b-PC complex | |
6CUG | 6CUG | Crystal structure of BC8B TCR-CD1b-PC complex | |
6CUF | Q2N0S6 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUF | 6CUF | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUF | Q2N0S7 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUE | Q2N0S7 | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUE | Q2N0S6 | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUE | 6CUE | Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CUD | Q13507 | Structure of the human TRPC3 in a lipid-occupied, closed state | Short transient receptor potential channel 3 |
6CU0 | P41273 | Crystal structure of 4-1BBL/4-1BB (C121S) complex in P21 space group | |
6CU0 | Q07011 | Crystal structure of 4-1BBL/4-1BB (C121S) complex in P21 space group | |
6CT6 | U6M598 | Crystal structure of lactate dehydrogenase from Eimeria maxima with NADH and oxamate | |
6CS2 | P59594 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | D9IEJ2 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | Q9BYF1 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS1 | P59594 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CS1 | D9IEJ2 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CS0 | P59594 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CS0 | D9IEJ2 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CRZ | P59594 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRZ | D9IEJ2 | SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRX | P59594 | SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CRX | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation | Spike glycoprotein,Envelope glycoprotein |
6CRW | P59594 | SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation | Spike glycoprotein,Envelope glycoprotein |
6CRW | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation | Spike glycoprotein,Envelope glycoprotein |
6CRV | P59594 | SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRV | D9IEJ2 | SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | Spike glycoprotein,Envelope glycoprotein |
6CRQ | Q2N0S5 | Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab | |
6CRQ | Q2N0S7 | Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab | |
6CRQ | 6CRQ | Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab | |
6CRD | P03472 | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) with tetrabrachion (TB) domain stalk | |
6CRD | 6CRD | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) with tetrabrachion (TB) domain stalk | |
6CRD | Q54436 | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) with tetrabrachion (TB) domain stalk | |
6CRD | P03472 | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) with tetrabrachion (TB) domain stalk | |
6CRD | 6CRD | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) with tetrabrachion (TB) domain stalk | |
6CRD | Q54436 | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) with tetrabrachion (TB) domain stalk |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024